Novel Obesity Drug Induces Weight Loss Up to 22% with No Safety Concerns in clinical trial Dr. Kamal Kant Kohli27 Jan 2025 10:00 AM ISTIn a phase 1b/2a trial subcutaneous amycretin demonstrated a safety profile similar to other incretin-based drugs . Adults with obesity experienced...
Pfizer, AstraZeneca and several other drugmakers in race to join weight loss drug market Ruchika Sharma23 Dec 2024 5:01 PM ISTPfizer, AstraZeneca, Amgen and several other drug developers aiming to join the weight-loss drug market, which is estimated to be worth about $150...
Medical Bulletin 12/ September/ 2024 Dr. Garima Soni12 Sept 2024 3:00 PM ISTHere are Top Medical News of the Day:Gene Therapy Improves Vision in hereditary blindness: Study FindsBothnia dystrophy is a form of hereditary...
13% Weight Loss Achieved Over Three Months With Amycretin: Phase 1 Trial Finds Dr. Garima Soni12 Sept 2024 8:45 AM ISTIndividuals who received a once-a-day oral weight loss drug lost up to 13% of their body weight over three months, new research was presented at the...
Novo Nordisk hopes to launch weight loss pill Amycretin this decade Ruchika Sharma11 March 2024 12:50 PM ISTNovo's current plan is to advance the development of amycretin in its oral and injectable form simultaneously, and it gives a regulatory advantage to...
